Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,693 | -50,380 | -46,150 | -39,014 | -24,620 |
| Depreciation Amortization | 4 | 3 | 2 | 1 | 8 |
| Accounts receivable | N/A | N/A | -50 | N/A | N/A |
| Accounts payable and accrued liabilities | 381 | 216 | 161 | 200 | 792 |
| Other Working Capital | 181 | 158 | -392 | -1,122 | 1,146 |
| Other Operating Activity | 36,757 | 36,279 | 36,289 | 34,123 | 15,877 |
| Operating Cash Flow | $-19,370 | $-13,724 | $-10,140 | $-5,812 | $-6,797 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | N/A | N/A | N/A | -1,475 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 2,014 |
| Investing Cash Flow | $-100 | $N/A | $N/A | $N/A | $539 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 646 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 23,347 |
| Common Stock Issued | 28,578 | 20,892 | 19,077 | 10 | 58 |
| Other Financing Activity | -1,619 | -1,317 | -1,102 | 0 | -2,285 |
| Financing Cash Flow | $27,605 | $19,575 | $17,975 | $10 | $21,120 |
| Beginning Cash Position | 16,399 | 16,399 | 16,399 | 16,399 | 1,537 |
| End Cash Position | 24,534 | 22,250 | 24,234 | 10,597 | 16,399 |
| Net Cash Flow | $8,135 | $5,851 | $7,835 | $-5,802 | $14,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,370 | -13,724 | -10,140 | -5,812 | -6,797 |
| Capital Expenditure | -100 | N/A | N/A | N/A | -1,475 |
| Free Cash Flow | -19,470 | -13,724 | -10,140 | -5,812 | -8,272 |